Centro de Investigaciones Reumatológicas

San Miguel de Tucumán, Tucumán Province T4000BRD

1 studies enrolling now · 11 studies all time

What they study most

Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Immune System Diseases, Joint Diseases, Lupus Erythematosus, Systemic, Lupus Nephritis, Musculoskeletal Diseases, Primary Sjogrens Disease, Rheumatic Diseases

Studies at this site

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) — Recruiting now
A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome — Running, not enrolling
A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity — Running, not enrolling
A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State — Running, not enrolling
An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc) — Stopped early
A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis — Stopped early
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease — Completed
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease — Completed
Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis — Completed
Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis — Completed
Study of LJP 394 in Lupus Patients With History of Renal Disease — Stopped early